Theranexus | ALTHX Logo | Annual Report & Investor Relations Data

Theranexus | ALTHX Annual Report & Investor Relations Data

ISIN

FR0013286259

Ticker

ALTHX

Sector

Health Care

Sub-Industry

Biotechnology

Country

France

Year Founded

2013

Theranexus (ALTHX)
Company Overview & Profile

Company Description

Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells.

Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease.

Served Area

Worldwide

Headquarters

Pépinière Laennec 60 Avenue Rockefeller
69008, Lyon
France

Theranexus (ALTHX)
Filings & Annual Reports

Filters

View all types
Type Document Details Language Filing Date File Number

Get Early API Access

Access comprehensive European stock market filings data through a single, powerful API.

700k+

filings covered

18

European countries

15min

max latency

1 API

for all filings

Request Early Access

Limited spots available. Join now!

Theranexus (ALTHX)
Leadership: Management & Supervisory Board

No Leadership Information Available

We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.

Theranexus (ALTHX)
Stock & Investor Information

ISIN

FR0013286259

LEI

969500BFCV6IC7MFQP20

Stock Exchange Listings

Euronext Paris

Primary Stock Exchange Listing

View Theranexus on main stock exchange

Industry Classification

Theranexus (ALTHX)
Related Companies in Biotechnology

4SC AG Logo

4SC AG

VSC

Sector

Health Care

Country

Germany

ISIN

DE000A3E5C40

Founded

1997

4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …

ABIONYX Pharma Logo

ABIONYX Pharma

ABNX

Sector

Health Care

Country

France

ISIN

FR0012616852

Founded

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …

Abliva Logo

Abliva

ABLI

Sector

Health Care

Country

Sweden

ISIN

SE0002575340

Founded

2000

Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …

AB Science Logo

AB Science

AB

Sector

Health Care

Country

France

ISIN

FR0010557264

Founded

2001

AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …

Acticor Biotech Logo

Acticor Biotech

ALACT

Sector

Health Care

Country

France

ISIN

FR0014005OJ5

Founded

Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of …

Active Biotech Logo

Active Biotech

ACTI

Sector

Health Care

Country

Sweden

ISIN

SE0001137985

Founded

1998

Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory …

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.

    We won't send you spam. Unsubscribe at any time.